MedPage Today September 24, 2025
Spending on pricey wound care products reached $10 billion in 2024
The HHS Office of the Inspector General (OIG) called out sky-high spending on pricey skin substitutes and voiced concerns about potential waste, fraud, and abuse in a report released earlier this month.
Spending on skin substitutes for the treatment of chronic wounds has soared over the last 2 years, reaching more than $10 billion in 2024 — more than 15% of the $66 billion in total spending for all Medicare Part B drugs that year, according to the HHS watchdog. (Part B generally covers medically necessary services and supplies, as well as certain outpatient prescription drugs and vaccines.)
In its report, the OIG highlighted several factors behind the rise...
Today's Sponsors
Today's Sponsor